Potential Therapy Discovered For Hypophosphatasia, A Congenital Form Of Rickets

Tuesday, June 3, 2008 - 16:14 in Health & Medicine

Researchers have demonstrated in mice the first successful use of enzyme replacement therapy to prevent hypophosphatasia, a primary skeletal disease of genetic origin. This discovery lays the foundation for future clinical trials for HPP patients.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net